1. Home
2. News
3. AF detection and diagnosis pathway - during and post COVID-19 recovery

AF detection and diagnosis pathway - during and post COVID-19 recovery

01 June 2023 (Last updated: 29 Jun 2023 12:34)

The launch webinar for the AF Detection and Diagnosis Pathway is now available to view on the PCCS CVD Academy! 

Please click here to view the pathway 

This resource has been co-developed by Trudie Lobban MBE, Dr Jim Moore, Professor Simon Ray, Helen Williams and the Stroke in Atrial Fibrillation Initiative (SAFI) which comprises the pharmaceutical companies Bayer, Daiichi Sankyo UK, Bristol Myers Squibb Pharmaceuticals Limited and Pfizer operating as the BMS-Pfizer Alliance. No funding has been provided by the SAFI group to individuals or organisations involved in the pathway co-development. SAFI has provided funding to Policy Matters as the SAFI secretariat to provide meeting logistics, practical assistance with materials development and support to co-ordinate pathway development. As SAFI will be disbanding, ownership of and responsibility for the pathway and associated materials will transfer to the Primary Care Cardiovascular Society following the launch on 2nd March 2023.

View other News